- Home
- NKTX vs PHD Comparison
NKTX vs PHD Comparison
Compare NKTX & PHD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKTX
- PHD
- Stock Information
- Founded
- NKTX 2015
- PHD 2004
- Country
- NKTX United States
- PHD United States
- Employees
- NKTX N/A
- PHD N/A
- Industry
- NKTX Biotechnology: Pharmaceutical Preparations
- PHD Investment Managers
- Sector
- NKTX Health Care
- PHD Finance
- Exchange
- NKTX Nasdaq
- PHD Nasdaq
- Market Cap
- NKTX 123.5M
- PHD 120.3M
- IPO Year
- NKTX 2020
- PHD N/A
- Fundamental
- Price
- NKTX $1.74
- PHD $9.75
- Analyst Decision
- NKTX Strong Buy
- PHD
- Analyst Count
- NKTX 6
- PHD 0
- Target Price
- NKTX $14.80
- PHD N/A
- AVG Volume (30 Days)
- NKTX 422.6K
- PHD 67.7K
- Earning Date
- NKTX 05-14-2025
- PHD 01-01-0001
- Dividend Yield
- NKTX N/A
- PHD 11.43%
- EPS Growth
- NKTX N/A
- PHD N/A
- EPS
- NKTX N/A
- PHD 1.27
- Revenue
- NKTX N/A
- PHD N/A
- Revenue This Year
- NKTX N/A
- PHD N/A
- Revenue Next Year
- NKTX N/A
- PHD N/A
- P/E Ratio
- NKTX N/A
- PHD $7.60
- Revenue Growth
- NKTX N/A
- PHD N/A
- 52 Week Low
- NKTX $1.31
- PHD $8.30
- 52 Week High
- NKTX $8.23
- PHD $9.81
- Technical
- Relative Strength Index (RSI)
- NKTX 45.11
- PHD 65.25
- Support Level
- NKTX $1.70
- PHD $9.70
- Resistance Level
- NKTX $1.82
- PHD $9.76
- Average True Range (ATR)
- NKTX 0.10
- PHD 0.06
- MACD
- NKTX -0.01
- PHD -0.00
- Stochastic Oscillator
- NKTX 18.82
- PHD 73.33
About NKTX Nkarta Inc.
Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.
About PHD Pioneer Floating Rate Fund Inc.
Pioneer Floating Rate Trust is a diversified, closed-end fund. It invests in the fixed income markets of the United States. The fund basically invests in senior secured floating-rate loans. It benchmarks the performance of its portfolio against the other High Yield Loans Index banks.